Silver Festin
Family · Columbia, MDNPI 1770259715
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.5% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 8.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,568 and has fallen 94.7% since, to $137 in 2025. Among family clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 147 payments — averaging $23.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$295
- Daiichi Sankyo Inc.$237
- Takeda Pharmaceuticals U.S.A., Inc.$217
- Incyte Corporation$205
- Johnson & Johnson$183
- Novartis$161
- plus $2K from 36 others
What the payments were for
- Food & beverage$3,25993%
- Education$2637%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 9 | $295 |
| Daiichi Sankyo Inc. | 13 | $237 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $217 |
| Incyte Corporation | 6 | $205 |
| Johnson & Johnson(2 entities) | 6 | $183 |
| Novartis | 7 | $161 |
| Pfizer | 6 | $138 |
| Bristol Myers Squibb | 6 | $130 |
| GSK | 4 | $121 |
| Amgen | 5 | $113 |
| Merck | 5 | $105 |
| Exelixis Inc. | 4 | $99 |
| Seagen Inc. | 4 | $95 |
| Lilly USA, LLC | 4 | $86 |
| CTI Biopharma Corp. | 1 | $85 |
| Sanofi-aventis U.S. LLC | 1 | $85 |
| Sanofi | 4 | $84 |
| Pharmacosmos Therapeutics Inc. | 4 | $73 |
| Heron Therapeutics, Inc. | 6 | $66 |
| Morphosys, US Inc. | 3 | $66 |
| Eisai Inc. | 3 | $61 |
| Tersera Therapeutics LLC | 2 | $58 |
| Novo Nordisk | 3 | $58 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $51 |
| Gilead | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Astellas Pharma US Inc | 2 | $48 |
| Puma Biotechnology, Inc. | 3 | $46 |
| Octapharma USA, Inc. | 2 | $46 |
| Coherus Oncology, Inc. | 2 | $46 |
| G1 Therapeutics, Inc. | 2 | $45 |
| Deciphera Pharmaceuticals Inc. | 2 | $42 |
| Genmab U.S., Inc. | 1 | $36 |
| Mirati Therapeutics, Inc. | 1 | $35 |
| Currax Pharmaceuticals LLC | 2 | $32 |
| AVEO Pharmaceuticals, Inc. | 2 | $30 |
| AbbVie | 1 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $28 |
| Boehringer Ingelheim | 1 | $27 |
| Taiho Oncology, Inc. | 1 | $24 |
| Array Biopharma Inc | 1 | $22 |
| Spectrum Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CALQUENCE$134
How this compares
$3,522 in reported general payments places this provider in the 90th percentile of 2,843 family providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alendronate Sodium | 12 | $229 |
| Lisinopril | 15 | $159 |
| Omeprazole | 15 | $51 |
| Quetiapine Fumarate | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other family in Columbia
- Caroline MoughonColumbia$25K
- Grace FitzpatrickColumbia$12K
- Tricia CarvalhoColumbia$9K
- Hannah ClevengerColumbia$9K
- Erika HoffmanPotomac$226K
- Caroline MansySalisbury$106K
- Hazel Jones-ParkerBaltimore$96K
- Brittany WilsonBaltimore$88K
- Ariana ChaoLutherville$85K
- Meredith SagalHunt Valley$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.